Skip to content

A Clinical trial to study the effect of Shula Prashamana Mahakashaya Taila (An Ayurvedic oil based medicine prepared out of Ayurvedic Drugs) in subjects with Gridhrasi vis-a-vis Sciatica

Critical Analysis of Samyogam ca prayogam ca yo veda sa bhishagvarah vis-a- vis Shula Prashamana Maha Kashaya - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/08/056113
Enrollment
75
Registered
2023-08-04
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M543- Sciatica

Interventions

None listed

Sponsors

Dr Suhas M
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Presence of Ruk, Toda, Stambha and Spandana in the Sphik, Kati, Uru and Pada 2. Tenderness along the course of the Sciatic nerve. 3. Patients in the age-group of 20-60 years.

Exclusion criteria

Exclusion criteria: 1. Benign or Malignant tumor of the spine or tuberculosis of the vertebral column. 2. Uncontrolled Diabetes Mellitus, Cardiovascular disease, Pregnancy and Lactating mother.

Design outcomes

Primary

MeasureTime frame
Efficacy of Shula Prashamana Maha Kashaya Taila in reducing the radiating pain in the patients of Gridhrasi by comparing the Numerical Pain rating scale, Sciatica Bothersome Index & Sciatica Frequency Index scores taken before & after the intervension.Timepoint: 9th day

Secondary

MeasureTime frame
Efficacy of Shula Prashamana Maha Kashaya Taila in relieving other associated symptoms of Gridhrasi like Sthambha (Stiffness of the affected limb), Gaurava (heaviness of the affected limb), Aruchi (tastelessness) & Tandra (listlessness).Timepoint: 9th day

Countries

India

Contacts

Public ContactDr Suhas M

Government Ayurveda Medical College and Hospital, Mysuru

dr.shreevathsa@rediffmail.com9449772701

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026